Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$33.7K
9.52K shares
What this filing means
NOUGUES MAXIMO F plans to sell 9.52K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $33.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2025ACC: 0001959173-25-004521
Officer· Chief Financial Officer
Since Nov 2018
9.52K
Shares to sell
$33.7K
Approx. market value
3.94K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/8/2025
3.94KTotal acquired3.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2025 | Restricted Stock Vesting Compensation | 3.94K | — |
| Total | 3.94K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.59K
Market value
$19.7K
7/8/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.94K
Market value
$13.9K
7/9/2025
Total
Units
9.52K
Value
$33.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2025 | 5.59K | $19.7K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2025 | 3.94K | $13.9K | NASDAQ | Planned |
| Total | 9.52K | $33.7K | ||